Drug resistant tuberculosisBMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6984.940b (Published 08 April 1995) Cite this as: BMJ 1995;310:940
- Brian I Duerden
- Deputy director Public Health Laboratory Service, University of Wales College of Medicine, Cardiff CF4 4XN
EDITOR,—P D O Davies highlights concern about drug resistant Mycobacterium tuberculosis and proposes a central laboratory for fast tracking molecular diagnostic tests for patients at risk.1 The concern is shared by many, including the Public Health Laboratory Service, but Davies shows a lack of knowledge of the facilities available and the status of diagnostic methods that use the polymerase chain reaction.
The Public Health Laboratory Service Mycobacterium Reference Unit (currently in Cardiff) has provided a central focus …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial